Citieffe is an Italy-based manufacturer specialising in the orthopaedic trauma and extremities segment with a direct presence in Italy, the US, and Mexico
Poly Medicure announced the signing of a definitive agreement to acquire 100 per cent stake in Medistream, consisting of Citieffe SRL and its step-down subsidiaries in the US and Mexico, at an Enterprise Value of Rs 324 crores. Citieffe is an Italy-based manufacturer specialising in the orthopaedic trauma and extremities segment with a direct presence in Italy, the US, and Mexico, and distribution across 25+ countries. The strategic acquisition provides Poly Medicure with an entry point into the large global orthopaedics market, particularly in the trauma and extremities segment, which is the fastest-growing and most resilient category within orthopaedics.
Himanshu Baid, Managing Director, Poly Medicure stated, “This acquisition marks another step in our journey to become a comprehensive healthcare solutions provider. Citieffe’s strong R&D capabilities and diverse trauma and extremity portfolio align with our mission to deliver innovative, patient-centric technologies. Together, we will be able to accelerate the expansion into orthopaedics adjacencies and expand reach to more patients globally. Citieffe has direct sales operations in the US, Italy, and Mexico, providing us a deeper foothold in these key markets. We see synergies in combining Citieffe’s innovation pipeline with Polymed’s manufacturing scale and commercial reach—this is about creating long-term value for healthcare providers, patients, and our stakeholders.”
Pascal Govi, CEO, Citieffe stated, “It has been a pleasure to work with ARCHIMED, who always acted as a responsible shareholder, notably during Covid times. Their commitment to invest in a stronger organization, international development and innovation was key to reinforce the strategic positioning of Citieffe. The company was well prepared for attracting a leading Medtech company such as Polymed. I’m enthusiastic to start a new venture with a group sharing a common culture and vision.”
Benoit Varichon, Partner, ARCHIMED stated, “We would like to thank CEO Govi and his team for their trust and outstanding achievement. Over the years, Citieffe has built solid and long-term growth foundations with an innovative and MDR-accredited product portfolio as well as a strong international footprint notably in the US. We are proud to see Citieffe joining a leading Medtech Group to pursue its growth trajectory.”
